Takeda Pharmaceutical (TAK) EBIT (QoQ) (2018 - 2026)
Takeda Pharmaceutical (TAK) EBIT (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.60% |
| Mar 31, 2026 | 147.49% |
| Dec 31, 2025 | -194.34% |
| Sep 30, 2025 | 124.74% |
| Jun 30, 2025 | 5.42% |
| Mar 31, 2025 | 345.59% |
| Dec 31, 2024 | -117.60% |
| Sep 30, 2024 | 161.96% |
| Jun 30, 2024 | -6.08% |
| Mar 31, 2024 | 89.80% |
| Dec 31, 2023 | -78.46% |
| Sep 30, 2023 | 126.25% |
| Jun 30, 2023 | -3.50% |
| Mar 31, 2023 | 22.51% |
| Dec 31, 2022 | 37.59% |
| Sep 30, 2022 | -35.03% |
| Jun 30, 2022 | -45.59% |
| Mar 31, 2022 | 108.75% |
| Dec 31, 2021 | 15.79% |
| Sep 30, 2021 | -61.02% |